These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21970911)

  • 21. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.
    Cole RE
    Postgrad Med; 2011 Mar; 123(2):131-44. PubMed ID: 21474901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of a strategy for the management of accompanying osteoporosis after inpatient treatment of fragility fractures].
    Bahrs C; Türk A; Eingartner C; Weise K; Rolauffs B; Stuby F
    Z Orthop Unfall; 2008; 146(1):52-8. PubMed ID: 18324582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hip Fracture--Epidemiology, Management and Liaison Service. Prevention of the secondary hip fractures utilizing the regional post-referral treatment plan].
    Matsushita M
    Clin Calcium; 2015 Apr; 25(4):545-50. PubMed ID: 25814015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary prevention of osteoporosis following fragility fractures of the distal radius in a large health maintenance organization.
    Benzvi L; Gershon A; Lavi I; Wollstein R
    Arch Osteoporos; 2016; 11():20. PubMed ID: 27142832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular disease, osteoporosis and risk of fracture].
    Reyes-García R; Rozas-Moreno P; Muñoz-Torres M
    Rev Clin Esp; 2012 Apr; 212(4):188-92. PubMed ID: 21798531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.
    Cortet B
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv14-9. PubMed ID: 19783589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial.
    Montori VM; Shah ND; Pencille LJ; Branda ME; Van Houten HK; Swiglo BA; Kesman RL; Tulledge-Scheitel SM; Jaeger TM; Johnson RE; Bartel GA; Melton LJ; Wermers RA
    Am J Med; 2011 Jun; 124(6):549-56. PubMed ID: 21605732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.
    Hiligsmann M; Vanoverberghe M; Neuprez A; Bruyère O; Reginster JY
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):359-66. PubMed ID: 20715911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures.
    Goltz L; Degenhardt G; Maywald U; Kirch W; Schindler C
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):263-70. PubMed ID: 23296590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The importance of taking care of osteoporosis].
    Rousière M
    Presse Med; 2011 Oct; 40(10):900-9. PubMed ID: 21493035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteosynthesis of fragility fractures.
    Tarantino U; Iundusi R; Lecce D; Tempesta V; Perrone FL; Rao C; Cerocchi I; Gasbarra E
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):54-6. PubMed ID: 21970924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approach to the Patient With Bone Fracture: Making the First Fracture the Last.
    Wang M; Seibel MJ
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3345-3352. PubMed ID: 37290052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project.
    Morell S; Hemmeler C; Amsler F; Gross T
    Swiss Med Wkly; 2017; 147():w14451. PubMed ID: 28695555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are hospitalized patients with fragile fractures managed properly in relation to underlying osteoporosis?
    Mehrpour SR; Aghamirsalim MR; Sorbi R
    J Clin Rheumatol; 2012 Apr; 18(3):122-4. PubMed ID: 22426584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures.
    Ding BTK; Lim HF; Johari F; Kunnasegaran R
    Osteoporos Int; 2023 Feb; 34(2):299-307. PubMed ID: 36409358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.
    Harvey NC; McCloskey EV; Mitchell PJ; Dawson-Hughes B; Pierroz DD; Reginster JY; Rizzoli R; Cooper C; Kanis JA
    Osteoporos Int; 2017 May; 28(5):1507-1529. PubMed ID: 28175979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.